Akshay Vaishnaw, MD PhD
Alnylam Pharmaceuticals
3
0
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Ross Andrew Soo, MBBS
National University Hospital, Singapore
Shared therapeutic areas:
Ruth A. Karron, MD
Johns Hopkins Bloomberg School of Public Health
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Jane Robertson, BSc, MBCHB, MD
AstraZeneca
Shared therapeutic areas:
Nina Bhardwaj, MD, PhD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
David Hui, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
John W Glod, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Gates MRI
Gates Medical Research Institute
Shared therapeutic areas:
William D Figg, Pharm.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus
Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 In Patients With Advanced Solid Tumors With Liver Involvement
Multi-center, Open Label, Extension Study of ALN-VSP02 in Cancer Patients Who Have Responded to ALN-VSP02 Treatment
All 3 trials loaded